Friday, November 30, 2018

Biocon, Mylan joint product Fulphila gets approval in EU

Biocon, Mylan joint product Fulphila gets approval in EU Fulphila, a biosimilar Pegfilgrastim, jointly developed by Biocon and Mylan, has been approved in European Union (EU), Biocon said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2BJpk7B

No comments:

Post a Comment

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...